Targeted RNA Sequencing Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2027

The Targeted RNA Sequencing Market report is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand, and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Market study provides comprehensive data that enhances the understanding, scope, and application of this report.

The Global Targeted RNA Sequencing Market Size is Projected to Reach at a CAGR of 28% during 2022-2027.

Click Here to Get a Free Sample Copy:

https://www.marketintelligencedata.com/reports/618687/global-targeted-rna-sequencing-market-size-status-and-forecast-2021-2027/inquiry?Mode=rukaiyya

Market Overview:

Targeted RNAseq is increasingly the method of choice for researchers studying the transcriptome. The clinical potential of RNAs as disease and treatment markers is fueling advances in RNA analysis methods. It offers numerous advantages over gene expression arrays as it is compatible with difficult samples such as formalin-fixed paraffin-embedded (FFPE) tissue, requires a low input of 10ng of total RNA or 20 – 100ng of FFPE RNA. It can also be applied to any species, even if reference sequencing is not available. A broader dynamic range enables more sensitive and accurate measurement of gene expression and a better value often delivering advantages at a comparable or lower price per sample than many arrays which are costlier in comparison to these. But as RNA sequencing data accumulates, and researchers compare findings, standardization has become a major issue.

Top Leading Companies:

Thermo Fisher, Illumina, Roche Holdings, BGI, Eurofins, LabCorp, Berry Genomics, Macrogen, GENEWIZ

Recent Developments

In May 2019, BGI (China) and GenomiQa (Australia) signed a services agreement for whole-genome sequencing on BGI’s DNBseqTM sequencing technology platform. Under this agreement, genomiQa will utilize BGI’s ISO15189 accredited laboratory sequencing facilities.
In November 2018, Illumina (US) acquired Pacific Biosciences (US), one of the leading provider of sequencing systems. This helped Illumina strengthen its sequencing product portfolio.
In June 2017, Agilent Technologies (US) and Agendia (US) entered into an agreement to expand their relationship to include the development of Agendia’s RNA-Seq kit version into Agilent’s current product portfolio.

Targeted RNA Sequencing Market Segmentation by Type:

Exome Sequencing
Enrichment Sequencing
Amplicon Sequencing

Targeted RNA Sequencing Market Segmentation by Application:

Research Institutes
Hospitals & Clinics
Biotechnology Company
Diagnostic Lab

Explore Full Report with Detailed TOC Here:

https://www.marketintelligencedata.com/reports/618687/global-targeted-rna-sequencing-market-size-status-and-forecast-2021-2027?Mode=rukaiyya

We will get in touch with you within 24hrs and help you find the research reports and Additional Customization you need.

Regional Targeted RNA Sequencing Market (Regional Output, Demand & Forecast by Countries)

North America (United States, Canada, Mexico)
South America (Brazil, Argentina, Ecuador, Chile)
Asia Pacific (China, Japan, India, Korea)
Europe (Germany, UK, France, Italy)
Middle East Africa (Egypt, Turkey, Saudi Arabia, Iran) And additional.

Buy Full Report Here:

https://www.marketintelligencedata.com/report/purchase/618687?mode=su?Mode=rukaiyya

Highlights of the Targeted RNA Sequencing Market Report:

Detailed overview of Targeted RNA Sequencing Market
Changing the Targeted RNA Sequencing market dynamics of the industry
In-depth market segmentation by Type, Application, etc.
Historical, current and projected Targeted RNA Sequencing market size in terms of volume and value
Recent industry trends and developments
Competitive landscape of Targeted RNA Sequencing Market
Strategies of key players and product offerings
Potential and niche segments/regions exhibiting promising growth.

The research includes historic data from 2016 to 2022 and forecasts until 2027 which makes the report an invaluable resource for industry executives, marketing, sales, and product managers, consultants, analysts, and stakeholders looking for key industry data in readily accessible documents with clearly presented tables and graphs.

Finally, the Targeted RNA Sequencing Market report is the believable source for gaining the market research that will exponentially accelerate your business. The report gives the principle locale, economic situations with the item value, benefit, limit, generation, supply, request, and market development rate and figure, and so on. Targeted RNA Sequencing industry report additionally Presents a new task SWOT examination, speculation attainability investigation, and venture return investigation.

We Offer Customization on Report Based on Specific Client Requirement:

– Free country Level analysis for any 5 countries of your choice.

– Free Competitive analysis of any 5 key market players.

– Free 40 analyst hours to cover any other data point.

ABOUT US:

Market intelligence data is a global front-runner in the research industry, offering customers contextual and data-driven research services. Customers are supported in creating business plans and attaining long-term success in their respective marketplaces by the organization. The industry provides consulting services, Market Intelligence Data research studies, and customized research reports.

Contact Us:

Irfan Tamboli (Head of Sales) – Market Intelligence information

Phone: + 1704 266 3234 | 750-707-8687

Email: sales@marketintelligencedata.com

This release was published on openPR.